The decline of inhibitors such as Matrix Gla Protein (MGP), Gla‐rich protein (GRP), osteoprotegerin (OPG), bone morphogenetic protein 7 (BMP‐7) and the increase of calcification inducers lead to more extensive VC in the CKD population.13, 14. This evidence concerns the gene MGP and chronic kidney disease.